Events

Oncorus®, Inc., Presents Preclinical Data on Next-Generation Oncolytic Virus Platform at American Association for Cancer Research (AACR) 2018 Annual Meeting

Oncorus®, Inc., Presents Preclinical Data on Next-Generation Oncolytic Virus Platform at American Association for Cancer Research (AACR) 2018 Annual Meeting

Oncorus®, Inc., a biotechnology company developing a next-generation immunotherapy platform of oncolytic viruses for the treatment of several tumor types, today announced that preclinical data about its oncolytic Herpes simplex virus (oHSV) immunotherapy platform will be presented at the American Association of Cancer Research (AACR) 2018 Annual Meeting to be held April 14-18, 2018 in Chicago, IL. 

Oncorus®, Inc., to Present at the 29th Annual Piper Jaffray Healthcare Conference

Oncorus®, Inc., to Present at the 29th Annual Piper Jaffray Healthcare Conference

Oncorus®, Inc., a biotechnology company developing a next-generation immunotherapy platform of oncolytic viruses for the treatment of several tumor types including highly malignant and aggressive cancers such as glioblastoma multiforme, today announced that its Chief Executive Officer and co-founder, Mitchell H. Finer, PhD, will present a company overview at the 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 at 3:30pm Eastern Time. The event will be held in New York at the Lotte New York Palace.